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Cellular/Molecular
Respiration-Deficient Astrocytes Survive As Glycolytic Cells
In Vivo
XLotti M. Supplie,1 XTim Du¨king,1 Graham Campbell,2 XFrancisca Diaz,3 XCarlos T. Moraes,3 Magdalena Go¨tz,4
Bernd Hamprecht,1 XSusann Boretius,5 XDonMahad,2 and XKlaus-Armin Nave1
1Max Planck Institute of Experimental Medicine, Department of Neurogenetics, D-37075 Go¨ttingen, Germany, 2Centre for Neuroregeneration, Chancellor’s
Building, Edinburgh EH16 4SB, United Kingdom,3Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136,
4Helmholtz ZentrumMu¨nchen, Deutsches Forschungszentrum fu¨r Gesundheit und Umwelt (GmbH), 85764 Neuherberg, Germany, and 5German Primate
Research Center, D-37077 Goettingen, Germany
Neurons and glial cells exchange energy-rich metabolites and it has been suggested, originally based on in vitro data, that astrocytes
provide lactate to glutamatergic synapses (“lactate shuttle”).Here,wehave studied astrocytes that lackmitochondrial respiration in vitro
and in vivo. A novelmousemutant (GLASTCreERT2::Cox10 flox/flox)was generated, inwhich the administration of tamoxifen causesmutant
astrocytes to fail in the assembly of mitochondrial cytochrome c oxidase (COX). Focusing on cerebellar Bergmann glia (BG) cells, which
exhibit the highest rate of Cre-mediated recombination, we found a normal density of viable astrocytes even 1 year after tamoxifen-
induced Cox10 gene targeting. Our data show that BG cells, and presumably all astrocytes, can survive by aerobic glycolysis for an
extended period of time in the absence of glial pathology or unspecific signs of neurodegeneration.
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Introduction
Maintaining brain function is dependent upon an uninterrupted
supply of energy. The electrical activity of neurons and synaptic
neurotransmission consume most of the cell’s ATP supply (At-
twell et al., 2010; Harris et al., 2012; Mergenthaler et al., 2013;
Rangaraju et al., 2014). A cellular network comprising brain cap-
illaries, astrocytes, and oligodendrocytes is thought to provide
energy-rich metabolites to neurons and their axonal and den-
dritic processes (Be´langer et al., 2011; Pellerin and Magistretti,
2012; Bouzier-Sore and Pellerin, 2013; Morrison et al., 2013;
Hirrlinger and Nave, 2014).
A specific role for astrocytes in the support of synaptic energy
metabolism was proposed by the “astrocyte-to-neuron lactate
shuttle” (ANLS) hypothesis (Pellerin and Magistretti, 1994). In
this model, astrocytes provide lactate to the glutamatergic syn-
apses that they engulf and astroglial glucose import is feed-back
regulated by glutamate uptake at the synaptic cleft. Simplified, it
was suggested that astrocytes perform aerobic glycolysis and re-
lease excess lactate into the synaptic compartment, thereby sup-
porting neuronal energy metabolism as a function of synaptic
activity (Pellerin and Magistretti, 1994, 2012; Pellerin et al., 1998;
Magistretti and Allaman, 2015).
In agreement with the ANLS hypothesis were human PET
studies showing that increases in cortical blood flow and glucose
uptake, triggered by neuronal activity, only partly match rises in
oxygen utilization (Fox and Raichle, 1986; Fox et al., 1988; Mag-
istretti, 2006; Rasmussen et al., 2011). Using magnetic resonance
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Significance Statement
Whenastrocytes are placed into culture, they import glucose and release lactate, an energy-richmetabolite readilymetabolized by
neurons. This observation led to the “glia-to-neuron lactate shuttle hypothesis,” but in vivo evidence for this hypothesis is weak.
To study astroglial energy metabolism and the directionality of lactate flux, we generated conditional Cox10 mouse mutants
lackingmitochondrial respiration in astrocytes, which forces these cells to survive by aerobic glycolysis. Here, we report that these
mice are fully viable in the absence of any signs of glial or neuronal loss, suggesting that astrocytes are naturally glycolytic cells.
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spectroscopy (MRS) imaging, the utilization of plasma-derived
13C-labeled lactate in neurons could be visualized directly (Bou-
mezbeur et al., 2010). Indeed, lactate can sustain neuronal activ-
ity in vivo and neurons exhibit a preference for lactate over
glucose when both metabolites are available (Wyss et al., 2011).
In culture, astrocytes metabolize glucose preferentially over lac-
tate, which is released into the medium and used by neurons
(Itoh et al., 2003; Bouzier-Sore et al., 2006). Purified neurons and
astrocytes also differ in the expression of glycolytic pathway
genes, which is higher in glia (Lovatt et al., 2007; Cahoy et al.,
2008; Zhang et al., 2014).
However, proving the cellular origin of lactate in the intact
CNS has been difficult. Glycogen granules are specific to astro-
cytes (Wender et al., 2000; Dienel and Cruz, 2015) and pharma-
cologically blocking glycogen breakdown in rats interferes with
hippocampal LTP and also suppresses the increase of lactate nor-
mally associated with memory formation (Suzuki et al., 2011).
Such behavioral data are compelling but remain indirect with
respect to the in vivo source of lactate. Indeed, it has been argued
that cortical astrocytes provide neurons with glucose and only
take up lactate from glycolytic neuronal domains to dispose of
excess lactate into the brain vasculature (Dienel, 2012; Hertz et
al., 2014).
For neurons, glycolysis is insufficient to generate all of the
ATP required for normal function and survival. Indeed, neurons
are unable to upregulate glycolysis due to low levels of Pfkfb3,
which generates the most potent activator of glycolysis (Herrero-
Mendez et al., 2009). Cortical and hippocampal neurons degen-
erate when mitochondrial respiration is impaired genetically
(Fukui et al., 2007; Diaz, 2010; Fu¨nfschilling et al., 2012). In these
in vivo experiments, the assembly of cytochrome c oxidase (COX)
was disrupted by Cre-mediated targeting of the nuclear Cox10
gene (Diaz et al., 2005), which is essential for COX assembly and
complex IV function. The same approach led to the surprising
finding that oligodendrocytes readily survive as glycolytic cells,
which are metabolically coupled to the axonal compartment that
they feed with lactate (Fu¨nfschilling et al., 2012). Indeed, loss of
the lactate transporter MCT1/Slc16a1 from oligodendrocytes
causes progressive axonal but not oligodendroglial degeneration
(Lee et al., 2012).
Here, we generated GlastCreERT2:Cox10 flox/flox mice in which a
large fraction of astrocytes, and virtually all Bergmann glia (BG) cells
of the cerebellum, lack mitochondrial respiration upon tamoxifen-
induced deletion ofCox10 (Diaz et al., 2005; Mori et al., 2006). Strik-
ingly, we observed fully viable but respiration-deficient astrocytes
even 1 year after gene targeting and in the absence of signs of glial
pathology, neurodegeneration, or inflammation.
Materials andMethods
Cell culture. Primary astrocytes were isolated as described previously
(Arai and Lo, 2010). Briefly, cortices dissected from postnatal day 2 (P2)
Sprague Dawley rat pups were digested in minimum essential medium
(MEM; Invitrogen) containing 2% cysteine (Sigma-Aldrich), 2% DNase
(Roche), and 4% papaine (Worthington) for 1 h at 37°C and 5% CO2.
Cells were plated onto 75 cm 2 flasks previously coated with poly-L-Lysine
(PLL, 10 g/ml; Sigma-Aldrich) and grown in DMEM (Lonza) supple-
mented with 10% heat-inactivated fetal calf serum (FCS; Hyclone), 1%
glutamine (Invitrogen), and 1% penicillin/streptomycin (Invitrogen) in
a humidified incubator at 37°C and 5% CO2. After mixed glial cell cul-
tures were confluent (12–14 d), nonastrocytic cells such as microglia and
oligodendrocytes were detached from the flasks by manual shaking and
removed by changing the medium. Astrocytes were dissociated by
trypsinization and 20,000 cells were reseeded on PLL-coated (0.1 mg/ml)
coverslips (13 mm). Astrocytic cultures were maintained in DMEM con-
taining 10% FCS, 1% glutamine, and 1% penicillin/streptomycin at 37°C
and 5% CO2. Human embryonic stem cell-derived astrocytes were cul-
tured as described previously (Joannides et al., 2007).
Primary neurons were isolated as described previously (Meberg and
Miller, 2003; Sinnamon et al., 2012). Briefly, cortices dissected from
embryonic day 17 Sprague Dawley rats were collected in ice-cold HBSS
without Mg 2 or Ca 2 with 5 mM HEPES and digested with 2.5% tryp-
sin (Invitrogen) in HBSS for 20 min at 37°C. Trypsinization was stopped
by adding 10% FCS in DMEM. Cortical homogenates were incubated
with 0.2 mg/ml DNase in DMEM for 5 min at room temperature and
subsequently dissociated carefully by 10 passes through a fire-polished
Pasteur pipette. The suspension was filtered through a 40m cell strainer
to remove debris. Then, 20,000 cells were plated on 13 mm coverslips
previously coated with PLL (10 g/ml) in a 24-well format. Cells were
cultivated in DMEM supplemented with 10% heat-inactivated FCS, 1%
glutamine, 1% penicillin/streptomycin, and 2% B27 supplement (Invit-
rogen) and maintained at 37°C and 5% CO2 in a humidified incubator.
The next day, the medium was changed to Neurobasal medium (Invit-
rogen) containing 1% glutamine, 1% penicillin/streptomycin, and 2%
B27 supplement. From there on, every 3– 4 d, a half medium change was
performed. To obtain pure neuronal cultures, cytosine arabinofurano-
side was added (to a final concentration of 5 M) at d in vitro 4 (DIV4)
and DIV8 to kill postmitotic glial cells.
Pharmacological inhibition of mitochondrial respiratory chain complex I
and complex IV and genetic disruption of complex IV in vitro. Rotenone
and potassium cyanide (KCN) were used to inhibit mitochondrial chain
complex I and complex IV, respectively. Rotenone treatments were con-
ducted for 24 h and initiated in astrocytes at DIV25 and neurons at
DIV10. Fresh rotenone powder (Sigma-Aldrich) was dissolved in di-
methyl sulfoxide to obtain a 10 mM solution. The final rotenone concen-
trations used in each experiment are indicated in the figures. At DIV21,
the human astrocyte monolayer was exposed to KCN, dissolved in
DMSO, for 24 h at varying concentrations (50M, 100M, and 1 mM). To
eliminate COX10 expression and to generate astrocytes lacking complex
IV in vitro, astrocytes were cultured from whole-brain homogenates
from Cox10 flox/flox mice. Cultured astrocytes were then exposed to len-
tiviral Cre (generated by Pamela Brown, University of Edinburgh) for
48 h and maintained for 8 weeks in vitro. Resuspended cells were then
used to assess oxygen consumption by respirometry, as described previ-
ously (Ziabreva et al., 2010).
Trypan blue exclusion. Cells were cultured as stated above and treated
in the presence or absence of rotenone. Subsequently, they were har-
vested by light trypsinization (5 min, 0.05% trypsin) and suspended in
defined medium. Next, cells were incubated in 0.4% trypan blue (Sigma-
Aldrich) solution for 5 min at room temperature (RT) and the number of
trypan blue-negative cells was counted using a hemocytometer to deter-
mine viable cells per 13 mm coverslip.
Immunocytochemistry. Cells were washed with 1 PBS, pH 7.4, fixed
with 4% (w/v) paraformaldehyde (PFA) for 15 min at 37°C, washed with
1 PBS, and permeabilized with 0.2% Triton X-100 and 10% horse
serum in 1 PBS for 1 h at RT. Primary antibodies were applied in the
same solution overnight at 4°C. Dilutions were as follows: for GFAP
(1:200, mouse; Novocastra), NeuN (1:100, mouse; Millipore), Tuj-1 (1:
200, rabbit; Covance), Vimentin (1:200, mouse; Novocastra NCL-VIM-
V9), and Aquaporin residue 249 –323 (1:100, rabbit; Sigma-Aldrich).
Secondary antibodies to mouse and rabbit conjugated to Alexa Fluor 488
and Alexa Fluor 555 (both 1:2000; Invitrogen) were incubated in 2%
horse serum in 1 PBS or PBS/BSA [1% (w/v) BSA] for 1 h at RT. For
nuclei labeling, DAPI (0.025g/ml final concentration) was added to the
secondary antibody. Coverslips were mounted using Aqua-Polymount
(Eppelheim).
Animals. All animal experiments were performed in compliance with
animal policies of the State of Lower Saxony, Germany. Animals were
maintained on a C57BL/6 genetic background. Cox10 flox/flox mice,
CKII-Cre mice, GLASTCreERT2 mice, and R26R-EYFP mice were geno-
typed as described previously (Minichiello et al., 1999; Srinivas et al.,
2001; Diaz et al., 2005; Mori et al., 2006). All tamoxifen-sensitive mutant
and control mice were treated with tamoxifen (Sigma-Aldrich) or the
vehicle oil only. Control mice received the vehicle or tamoxifen when
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GlastCreERT2 was present or not, respectively. Tamoxifen was dissolved in
corn oil to obtain a 10 mg/ml solution. Mice were injected intraperito-
neally with a tamoxifen dosage of 100 mg/kg body weight for 5 consecu-
tive days starting at P30. For the proliferation assay, mice were exposed to
0.2 mg/ml 5-ethynyl-2-deoxyuridine (EdU; Invitrogen) in the drinking
water at the age of 2 months for 14 d. EdU solution was freshly prepared
every 2 d.
PCR on genomic DNA. A total of 30 g of total cerebellar and brain
DNA was used in a PCR to detect the recombined Cox10 allele with the
primers TGAGTAGAATGGCTTCCGGAAGGG and AGCAGCAAA-
GAGGGCTCACTTCTTGC, generating a template of 465 bp. For each
genotype, three female mice were analyzed.
Immunohistochemistry. Mice were anesthetized with Avertin [2,2,2-
tribromoethanol [2% (v/v)] and amyl alcohol [2% (w/v)], 0.2 ml per 10 g
body weight] and perfused intracardially with 15 ml of HBSS and subse-
quently with 4% (w/v) PFA in 0.1 M sodium phosphate buffer. Brains
were kept in the same fixative overnight at 4°C and then either embedded
in paraffin or cut using a vibratome.
For reporter studies, 30-m-thick cerebellum sections were cut
sagittally with a vibratome. Sections were washed with 1 PBS and
permeabilized with 0.2% Triton X-100 and 5% horse serum in 1
PBS for 1 h at RT. Primary antibodies against GFP (1:1000, goat;
Rockland) and S100 (1:200, rabbit; Abcam 52642) were applied in
the same solution overnight at 4°C. For each genotype, four mice of
either sex were analyzed.
For fluorescent immunolabeling, 5m paraffin sections were cut using a
microtome. After deparaffinization and rehydration, sections were boiled
for 10 min in 0.1 M citrate buffer, pH 6.0, in a microwave (650 W). After
cooling down to RT, sections were rinsed with 0.05 M Tris buffer, pH 7.6,
containing 2% (w/v) fat-free milk powder and incubated in blocking solu-
tion containing 20% goat serum in 1 PBS for 30 min at RT. Primary
antibodies GFAP (1:200, mouse; Novocastra) and S100 (1:200, rabbit; Ab-
cam 52642) were diluted in BSA/PBS and incubated overnight at 4°C. For
each genotype, three to six mice of either sex were analyzed.
Secondary antibodies to mouse, goat, and rabbit conjugated to Alexa
Fluor 488 (1:2000; Invitrogen) and Alexa Fluor 555 (1:2000; Invitrogen)
in 2% horse serum in 1 PBS or PBS/BSA [1% (w/v) BSA] were incu-
bated for 2 h at RT. For nuclei labeling, DAPI (0.025g/ml final concen-
tration) was added to the secondary antibody. Sections were mounted
using Aqua Polymount.
For chromogenic staining, paraffin sections (5 m) were immunola-
beled with antibodies against APP (1:750, mouse; Millipore), CD3 (1:
150, rat; Serotec), Mac3 (1:400, rat; Millipore), and GFAP (1:200, mouse;
Novocastra) using the LSAB2 kit (Dako), the Vector Elite ABC kit (Vec-
tor Laboratories), and the Zytomed kit (Zytomed Systems) according to
the manufacturer’s instructions. For each genotype, three to six mice
were analyzed. For the quantification of CD3-positive T cells and Mac3-
positive microglia, nuclei surrounded by DAB-positive deposits
were quantified using the Cell Counter plug-in of ImageJ. For semiauto-
mated analysis of the GFAP-positive area, our own ImageJ plug-in
(http://www1.em.mpg.de/Goebbels2016_GFAP) was used. For each ge-
notype, four to six mice of either sex were analyzed.
For hematoxylin staining, sections were deparaffinized, rehydrated,
and incubated in 0.1% hematoxylin for 3–5 min. For each genotype,
three to six mice of either sex were analyzed.
For TUNEL staining, paraffin sections were treated with DeadEnd
Colorimetric TUNEL System kit (Promega) following the manufac-
turer’s instructions. For each genotype, three to six mice of either sex
were analyzed.
The proliferation assay was performed on paraffin sections using the
Click-it EdU Alexa Fluor 555 Imaging kit (Invitrogen) after immuno-
labeling. The tissue was permeabilized with 0.5% Triton X-100 and 3%
horse serum in 1 PBS for 1 h at RT and the following steps were
performed according to the manufacturer’s instructions. For each geno-
type, three to four female mice were assessed.
COX/SDH histochemistry. Sequential histochemistry was performed
to detect COX and succinate dehydrogenase (SDH, also known as mito-
chondrial complex II) activity as described previously (Campbell et al.,
2011). Briefly, 8-mm-thick brain sections were cut using a cryostat and
air dried for 30 min at RT. Astrocytes were removed from medium and
the coverslips were air dried for 30 min at RT. Cryosections and astro-
cytes on coverslips were exposed to COX medium containing 500 M
cytochrome c, 5 mM diaminobenzidine tetrahydrochloride, and 20g/ml
catalase at 37°C for 40 min. Sections were washed 3 times with 1 PBS,
followed by application of SDH medium containing 130 mM sodium
succinate, 200 mM phenazine methosulphate, 1 mM sodium azide, and
1.5 mM nitroblue tetrazolium in 0.1 M phosphate buffer, pH 7.0, for 30
min at 37°C. For each genotype, three mice of either sex were analyzed.
Electron microscopy. Mice were anesthetized with Avertin, perfused
intracardially with 15 ml of HBSS and subsequently with 4% (w/v) PFA
and 2.5% (v/v) glutaraldehyde in 0.1 M sodium phosphate buffer. Brains
were kept in the same fixative for postfixation overnight. Cerebellar lobe
3 was punched out from 300-m-thick sagittal cerebellar sections, dehy-
drated in an ascending series of ethanol, and then embedded in Epon.
Ultrathin sections (50 nm) were cut using an ultramicrotome (Ultracut
S) and contrasted with 4% uranyl acetate, followed by application of lead
citrate (Reynolds, 1963). EM images from the upper third of the molec-
ular layer were acquired at 5000with an electron microscope (Leo 912;
Zeiss). For each genotype, four to six female mice were analyzed and, for
each animal, 10 random photographs were taken. Synapses between par-
allel fiber (PF) axons and Purkinje cell (PC) dendrites were identified
by morphological characteristics (Yamada and Watanabe, 2002) and
counted using the Cell Counter plug-in of ImageJ. BG processes were
identified by their irregular appearance and characteristic bundles of
intermediate filaments in a relatively clear cytoplasm (Palay and Chan-
Palay, 1974). The area of BG processes was analyzed with the point-hit
method with a defined grid area of 2.0 m 2 using ImageJ. EM images
from the PC layer were acquired at 3150. For each genotype, three
female mice were analyzed. BG were identified by their localization and
morphological features (Palay and Chan-Palay, 1974). The area of BG
cytoplasm was measured and the number and size of BG mitochondria
were determined using ImageJ.
Localized proton MRS. Mice [Cox10 fl/fl-GLAST-Cre (n  11) and
Cox10 fl/fl controls] were initially anesthetized with 4% isoflurane and
subsequently intubated and kept under anesthesia with 1.75% isoflurane
in ambient air enriched with 20% oxygen (positive pressure ventilation,
constant respiratory frequency of 85/min).
Localized proton MRS was performed at a field strength of 9.4 T
(Bruker Biospin) by using a STEAM sequence (TR/TE/TM 6000/10/10
ms, outer volume suppression, water suppression with CHEmical Shift
Selective (CHESS) pulses). T2-weighted images (2D SE, TR/TE 
2500/20 ms, spatial resolution 130  130 m 2, slice thickness 300 m,
axial and sagittal orientation) were used for positioning of the volumes of
interest. Spectra were obtained in the midfrontal cortex (3.9 0.7 3.2
mm 3, number of averages 128) and the cerebellum (4  1  2 mm 3,
number of averages 128). Metabolite quantification involved spectral
evaluation by LCModel (Version 6.3–1L) and calibration with a brain
water concentration of 43.7 mol/L. Values with Cramer–Rao lower
bounds20% were excluded from further analyses. For each genotype,
four to five female mice were analyzed.
Statistics. Statistical significance was evaluated using unpaired Stu-
dent’s t test. Values are represented as mean  SEM. p  0.05 was
considered statistically significant.
Results
Cultured astrocytes resist mitochondrial respiratory chain
complex I and complex IV inhibitors that are toxic for
neurons
To compare the ability of cultured astrocytes and neurons to
survive by glycolysis in the presence of oxygen, purified cells were
treated with rotenone, a plant-derived inhibitor of the mitochon-
drial respiratory chain complex I (Lindahl and Oberg, 1961), and
potassium cyanide, a COX inhibitor (Campbell et al., 2011). As
expected, cortical neurons were very sensitive to the pharmaco-
logical inhibition. Addition of as little as 10 nM rotenone led to a
striking reduction of Tuj1-positive neuronal processes 24 h later
and apoptotic cells with pyknotic nuclei were obvious (Fig. 1A).
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At higher concentrations of rotenone, we observed complete
neuronal loss within 24 h. In contrast, the exposure of astrocytes
to 10 – 40 nM rotenone for 24 h caused no obvious alteration of
morphology (Fig. 1B) and no signs of cell death when quantified
by trypan blue exclusion (Fig. 1C); this was expected because
astrocytes are resistant to anoxia (Kelleher et al., 1993). Likewise,
the addition of KCN at doses lethal to neurons (Campbell et al.,
2011) was also well tolerated by both human astrocytes (Fig. 1D)
and mouse astrocytes (data not shown) despite previously re-
ported species differences in cultured astrocytes (Ahlemeyer et
al., 2013). We therefore aimed to target mitochondrial complex
IV in vivo, the functional loss of which is only associated with a
delayed generation of ROS (Diaz et al., 2012), using a long-term
in vivo approach in mutant mice.
Astrocyte-specific recombination of Cox10 and loss of
cytochrome c oxidase
To determine whether adult astrocytes in the living brain
are dependent on oxidative phosphorylation, we crossbred
Cox10 flox/flox mice (Diaz et al., 2005) with a tamoxifen-sensitive
GLASTCreERT2 driver line that targets astrocytes selectively in a
temporally controlled fashion (Mori et al., 2006; Buffo et al.,
2008). In the absence of the farnesyl-transferase Cox10, func-
tional COX cannot be assembled, as shown in other mouse mod-
els in which mutant cells either die or survive by aerobic glycolysis
(Fukui et al., 2007; Fu¨nfschilling et al., 2012).
Mice received daily tamoxifen injections for 5 consecutive
days beginning at P30. Age-matched control mice were homozy-
gous for the floxed Cox10 allele, but either lacked GLASTCreERT2
(when injected with tamoxifen) or expressed GLASTCreERT2 but
received vehicle only. In the adult rodent brain, the half-life of
mitochondria is 24 –26 d (Beattie et al., 1967; Menzies and Gold,
1971). First histological and electron microscopy analyses were
therefore performed at 3 months of age (Fig. 2A), when we ex-
pected a significant loss of mitochondrial respiration, and neuro-
nal Cox10 mutants are clearly affected (data not shown). Later,
we investigated long-term effects in Cox10 mutant mice at 1
year of age. All mutant mice were obtained at the expected Men-
delian ratio, long-lived and indistinguishable in the cage from
control littermates.
Recombination of the floxed Cox10 locus was confirmed by
PCR analysis of genomic DNA (Fig. 2B) purified from the cere-
bellum and the cerebrum. For both brain regions, we could de-
termine the loss of exon 6 by the emergence of a 465 bp DNA
fragment (Fig. 2C). From genomic DNA of control mice, no
corresponding PCR product could be amplified.
Specificity of Cre recombination was addressed by cross-
breeding Cox10 flox/flox::GLASTCreERT2 mice to the reporter strain
R26R-EYFP (Srinivas et al., 2001), leading to the excision of a
floxed “stop” sequence and expression of yellow fluorescent pro-
tein (YFP). Positive identification of astrocytes was achieved by
colabeling YFP cells for S100, a calcium-binding protein and
widely used astrocyte marker (Donato, 1991).
As expected, inducible GLASTCreERT2 expression was mosaic
for cortical astrocytes (Mori et al., 2006). In the somatosensory
cortex 55% of S100-marked astrocytes were Cre recombined. In
Figure 1. Cultured astrocytes resist mitochondrial respiratory chain complex I and complex IV inhibitors that are toxic for neurons. A, Cultures of rat cortical neurons were treated with rotenone
for 24 h (concentrations as indicated) and immuostained for TuJ1 (red) and NeuN (green). Toxicity is indicated by the loss of staining and pyknotic neuronal nuclei (DAPI). Insets show condensed
neuronal nuclei at higher magnification. Scale bars, 50 and 10m. B, Cultured astrocytes were treated with rotenone for 24 h (concentrations as indicated) and immunostained for GFAP (green).
C, Quantified by a trypan blue exclusion assay, rotenone treatment did not affect astrocyte survival. Data are shown as mean SEM. D, Cultured human astrocytes, immunostained for vimentin
(green) and aquaporin-4 (red), were resistant to KCN administered at low (50M) and high (1 mM) concentrations. Scale bar, 50m. n.s., Not significant.
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the cerebellum, on average, 75% of all S100-positive astrocytes
were Cre recombined, including 25% EYFP-labeled astrocytes in
the granule cell layer and underlying white matter (Fig. 2D).
However, cerebellar BG cells, a subgroup of astrocytes localized
in the PC layer (Yamada and Watanabe, 2002), revealed a very
high degree (93  2.4%) of recombination (Fig. 2D,E). There-
fore, further analyses focused on these cells.
To demonstrate functional loss of mitochondrial respiration
in BG, we performed sequential COX and SDH histochemistry
(Fig. 3A,B), a widely used technique to identify mitochondrial
dysfunction (Campbell et al., 2011; Fu¨nfschilling et al., 2012).
This technique revealed the absence of cytochrome c oxidase ac-
tivity from Cox10-deficient astrocytes by virtue of a characteristic
blue precipitate that cannot form in wild-type cells and their
processes (Fig. 3C,D). Here, cytochrome c oxidase generates a
brown precipitate that prevents the subsequent formation of a
blue SDH reaction product. To demonstrate the efficient loss of
COX activity on the single-cell level, we cultured primary astro-
cytes obtained from Cox10-floxed mice for 8 weeks (allowing for
mitochondrial protein turnover), transduced them with a Cre-
expressing lentivirus, and applied COX/SDH histochemistry.
The emergence of the blue and the absence of the brown precip-
itate when only COX medium was added to Cox10-floxed astro-
cytes upon lentiviral-mediated Cox10 depletion indicates the
reliable inactivation of cytochrome c oxidase in all astrocytes
(Fig. 3E).
The fact that we observed Cox10-deficient BG in 1-year-old
mutants implies that these astrocytes must have survived in the
absence of mitochondrial respiration as glycolytic cells. There-
fore, we hypothesized that astrocytes survived by increasing ATP
production by aerobic glycolysis and predicted that elevated lac-
tate levels would be detected in vivo in Cox10 mutant brains.
Figure 2. Inducible deletion of Cox10 and specific reporter gene recombination. A, GLASTCreERT2:Coxflox/flox mice (age P30) were tamoxifen injected for 5 consecutive days and analyzed
months later as indicated. B, Schema of the floxed Cox10 gene with the excision of exon 6 (not drawn to scale). Arrows indicate the location of PCR primers. C, Verification of Cox10 genomic
recombination in mutant brains and cerebelli at the age of 3 months. D, Estimated recombination efficiency of GLASTCreERT2 mice in the cortex (ctx) and cerebellar subregions (pcl, PC layer; gcl,
granule cell layer; wm,whitematter) by analysis of R26R-EYFP reporter gene expression. Astrocytes, identified by S100 colabeling,were up to 93% recombinant (mean SEM). E, Virtually all BG
marked with S100 (top: red channel) expressed EYFP (middle: green channel, immunostained). Black and white images have been pseudocolored in the bottom panel. Scale bars, 50m.
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Localized proton MRS detecting levels of different metabolites,
among them lactate, was performed in aged mice (20 –25
months). Indeed, under isoflurane anesthesia, Cox10 mutant
mice showed increased brain lactate concentrations (Fig. 3F).
When quantified, we determined in the cerebellum 6 mM in
mutant and 4 mM in control mice (in the cortex, 4 mM in
mutant and3 mM in control, data not shown) (Fig. 3G).
Normal cerebellar organization and survival of BG cells
By histological staining (hematoxylin) at the age of 3 months and
14 months, loss of mitochondrial respiration in astrocytes did not
affect the gross morphology of the cerebellum (or any other
brain area). At both ages, cerebellar size and cytoarchitecture
were unaffected in mutant mice (Fig. 4A and data not shown).
When stained for S100 and coimmunolabeled for GFAP, the
density and morphology of BG cells and their many processes
were indistinguishable from wild-type (Fig. 4B,C). Therefore,
4
Figure 3. Sequential COX/SDH histochemistry proving the loss of COX activity in BG cells.
A, Identification of respiration deficient (COX neg.) cells by sequential COX/SDH histochemistry.
In control cells, COXactivity generates abrownprecipitate andprevents theemergenceof ablue
precipitate by the SDH reaction, which therefore marks mutant cells. B, Scheme illustrating
mutant BG in the PC layer (blue, arrowheads) next to PCs (brown, COX active) as shown below.
C, In control mice, mitochondrial COX activity leads to a brown precipitate in all cells of the
cerebellum (age 14 months). D, In age-matched mutant mice, the blue precipitate marks BG
cells (white arrows). Note also blue spots in the granule cell layer indicating astrocytes. Scale
bar, 50m, E, Lentiviral-mediated deletion of Cox10 in cultured astrocytes maintained for 8
weeks in vitro leads to inactive cytochrome c oxidase in all astrocytes, as detectable by the
emergence of a blue precipitate and the absence of a brownprecipitatewhen only COXmedium
was applied. Scale bar, 100m. F, Localized proton MR spectra obtained from the cerebellum
(voxel size: 4  1  2 mm3) revealed increased lactate concentrations in GlastCre
ERT2/*COX10fl/fl mice.G, When quantified, mutantmice revealed a concentration of 6.2
0.2 mM (controls 4.5 0.4 mM). Lac, lactate; Cr, creatine; NAA, N-acetylaspartate; rec., Cre
recombined; ml, molecular layer; pcl, PC layer; gcl, granule cell layer.
Figure 4. Cerebellum and BG cell morphology in Cox10 conditional mutant mice. A, Hematoxylin staining showing that the cerebellum appears normal in mutant mice (14 months).
Scale bar, 500m. B, Single BG cells colabeled for S100 (red) and GFAP (green) were morphologically indistinguishable in 14-month-old mutant mice and controls. Asterisks mark PCs
(unstained). Scale bar, 100m. C, Quantification of BG cell numbers at the age of 3 and 9 –10months.D, At the electronmicroscope level, mutant BG exhibit glycogen inclusion of normal
size and mitochondria are morphologically unaffected (age 10 months). Scale bar, 500 nm. E, Quantitation of mitochondrial data. Numbers are mean SEM. G, Glycogen; N, nucleus;
M, mitochondria; n.s., not significant.
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respiration-deficient BG survive well in vivo. As shown by elec-
tron microscopy, these cells exhibited glycogen granules of nor-
mal size and their mitochondria were unaltered in size and
number (Fig. 4D,E).
Analysis of glial cell death, neurodegeneration,
and regeneration
CNS integrity could theoretically be preserved when Cox10 mu-
tant astrocytes are replaced by newly generated astrocytes that
have escaped Cre recombination. We explored the proliferation
index of astrocytes by a 2-week daily treatment with EdU begin-
ning 50 d after tamoxifen-induced deletion of Cox10. By costain-
ing for S100, we only detected sporadic EdU-labeled astrocytes.
Similarly, the proliferation of EdU cells in the cerebella of
Cox10 mutants and controls was the same (Fig. 5A,B).
To detect apoptotic mutant cells directly, we performed a
TUNEL assay. No evidence for increased apoptotic cell death was
found in the brains of mutant or age-matched control mice at the
ages of 3 and 10 months (Fig. 5C and data not shown). For com-
parison, when using CKII-Cre mice to delete Cox10 in cortical
neurons (beginning at age P5–P10), we observed massive apo-
ptosis of projection neurons in the forebrain at 4 months (Fig.
5D). As shown previously, these mice suffer from severe neuro-
degeneration, confirming that neuronal survival requires oxida-
tive phosphorylation (Fukui et al., 2007; Diaz, 2010), a striking
difference from the survival of mutant glial cells.
Lack of secondary neuroinflammation
Neuroinflammation is a sensitive response to perturbations of
CNS integrity and metabolic distress (Xanthos and Sandku¨hler,
2014). However, we found no evidence for astrogliosis by GFAP
immunostaining of brains from 14-month-old Cox10 mutant
mice (Fig. 6A). Immunostaining for Mac3, an inducible marker
of activated microglia, revealed no alterations compared with
age-matched controls (Fig. 6B). We detected a few CD3 T cells
in brain sections, but they were comparable in number to control
brains (Fig. 6C). The accumulation of APP-positive endosomes
in axonal spheroids is a sign of disturbed axonal transport and a
key feature of respiration-deficient cortical projection neurons.
However, conditional Cox10 flox/flox::GLASTCreERT2 mutants did
not exhibit any APP accumulation at the two ages tested (Fig. 6D
and data not shown).
BGmorphology and synapse density
Astrocytes contribute to the formation and maintenance of func-
tional synapses. To explore whether respiration-deficient BG
cells and their processes cause morphological changes of synapses
between PF axons and PF dendritic spines, we performed an
electron microscopy study. Quantification of PF–PC synapse
density in the upper part of the cerebellar molecular layer re-
vealed no significant difference between Cox10 mutant mice and
controls (Fig. 7A,B). We then investigated whether BG processes
surrounding the PF–PC synapses are morphologically intact.
Swollen processes could indicate lactate accumulation (Rehnc-
rona, 1985), whereas retracted processes would suggest synaptic
dysfunction. However, we observed no morphological differ-
ences and the calculation of BG “process area” in mutants and
controls was the same at both 3 and 10 months of age (Fig.
7A,C). Moreover, mitochondrial density in BG processes was
not affected in mutants compared with age-matched controls
(Fig. 7D). This is in agreement with our conclusion that gly-
colytic astrocytes are healthy and maintain normal brain func-
tions in vivo.
Discussion
The cellular origin and metabolic fate of brain lactate has been
difficult to study in vivo, which has led to diverse hypotheses,
often based on conflicting data obtained in vitro (Pellerin and
Magistretti, 1994; DiNuzzo et al., 2010; Dienel, 2012; Bouzier-
Sore and Pellerin, 2013; Hertz et al., 2014; Patel et al., 2014; Mag-
istretti and Allaman, 2015; Ma¨chler et al., 2016). Direct in vivo
approaches to determine the origin of endogenously generated
Figure 5. Survival of BG cells in conditional Cox10mutantmice.A, As shown by EdU labeling,mitotic cells (in red) and S100-positive astrocytes (in green) were not costained in the cerebellum
of Cox10 mutant and control mice (arrowhead indicates a mitotic nonastrocytic cell). Scale bar, 20m. B, When quantified, the total number of EdU-positive cells is not different in the mutant
cerebellum. Data are shown asmean SEM. cer. sec., Cerebellar section. C,D, No signs of cell death in the cerebellumwere observed by TUNEL staining (age 3months; C), in contrast to a positive
control (D), where Cox10 mutant neurons undergo apoptosis in the forebrain of CKII-Cre*Cox10fl/fl mice (age 4 months). Scale bar, 100m. n.s., Not significant.
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brain lactate are technically difficult to implement. To address
the question of whether astrocytes in the living brain are, at least
in principle, a continuous source of lactate for neighboring cells,
we generated a new mouse model in which astrocytes that could
not survive by aerobic glycolysis alone would simply die. This was
possible by genetically targeting Cox10 and inactivating the
mitochondrial complex IV (COX) in a large subset of adult
astrocytes. Successful recombination of the tamoxifen-inducible
GLASTCreERT2 mouse line (Mori et al., 2006) was shown by re-
porter gene expression (EYFP) of nearly all BG cells in the cere-
bellum (Srinivas et al., 2001). The extent of recombination in
cortical astrocytes may have been underestimated in the R26R-
EYFP reporter mice. Successful elimination of mitochondrial res-
piration in BG was shown by the absence of COX activity (by
sequential COX/SDH histochemistry), even in aged mutant
mice, and the efficient inactivation of COX on a single-cell level
was demonstrated in cultured Cox10-floxed astrocytes. COX/
SDH histochemistry is a very specific technique in which the
complete loss of mitochondrial cytochrome c oxidase activity is
detected reliably. If anything, the opposite poses a problem: that
COX deficiencies are overlooked in mitochondrial diseases be-
cause the reaction products saturate despite significantly reduced
enzymatic activity (Mahad et al., 2009; Rocha et al., 2015)
Cox10mutant cells are forced to live glycolytically, so lactate is
a necessary by-product generated to maintain the NAD/NADH
ratio required for continuous glycolysis (as shown in Cnp1-Cre::
Cox flox/flox mice by Fu¨nfschilling et al., 2012). As shown by
localized proton MRS, elevated lactate concentrations in the cer-
ebellum of Cox10 mutant mice could be observed in vivo under
isoflurane anesthesia (from 4.5 mM to 6 mM in mutant cere-
bella), demonstrating that mutant astrocytes survive by sufficient
ATP supply from enhanced aerobic glycolysis. Given that the
these measurements include a large background of genetically
wild-type cells (mostly cerebellar granule cells), the data demon-
Figure 6. No signs of inflammation and neurodegeneration were seen in Glast-Cre::Cox10mutant mice. A, Immunostaining of sagittal cerebellar sections for GFAP revealed no signs of gliosis in
mutantmice (age 14months).B, ActivatedMac3-positivemicroglia (arrowheads)were notmore frequent inmutant than in controlmice. C, Invading T-cells, immunostained for CD3 (arrowheads),
were not significantly increased in mutants compared with age-matched controls. D, As shown by APP immunostaining, axonal swellings were not observed in control and Glast-Cre::Cox10fl/fl
mutant mice, in contrast to the forebrain of CKII-Cre::Cox10fl/fl mice (positive control, right). All sections are counterstained with hematoxylin (blue). Scale bars, 100m. Numbers are mean
SEM. n.s., Not significant.
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strate that mutant astrocytes are a source of elevated lactate levels
and this lactate is neither stored as glycogen nor metabolized by
OXPHOS in these astrocytes, but rather shuttled out of mutant as-
trocytes. Indeed, in this experimental situation, purely glycolytic
astrocytes will use more of the available glucose than normal,
which may increase the lactate utilization by “glucose-
starved” neurons. Therefore, the flow rate of lactate (from
astrocytes to neurons) may be higher in mutant compared
with wild-type brains.
Mutant GLASTCreERT2::Cox flox/flox mice, observed up to 14
months of age, were phenotypically indistinguishable from con-
trols. The cerebellum and all other CNS areas investigated were
histologically normal, including the morphology and density of
BG cells themselves, and this was also consistent with the normal
survival of rotenone- and potassium cyanide-treated astrocytes
in vitro. Importantly, no change in mitochondrial numbers or
mitochondrial morphology was detected. The possibility that mi-
tochondrial respiration might persist due to fusion or fission
events is highly unlikely because Cox10 is a nuclear gene and its
recombination leads to the gradual loss of complex IV from all
mitochondria. We note that swellings have been observed as signs
of “unphysiological” mitochondrial dysfunction, for example, in
Cox10-deficient skeletal muscle cells, hepatocytes, and Schwann
cells (Diaz et al., 2005, 2008; Fu¨nfschilling et al., 2012). Our find-
ings here suggest that a physiological adaptation has taken
place, possibly as a result of normal astroglial differentiation,
which could include a developmental “metabolic switch,” but
this possibility needs to be further investigated. We note that a
similar metabolic switch has been associated with the differ-
entiation of myelinating oligodendrocytes (Fu¨nfschilling et
al., 2012) and is reminiscent of the “Warburg effect” in many
tumor cells (Gatenby and Gillies, 2004).
Axonal swellings, APP accumulation, and neuroinflammation
comprise a sensitive response to neurodegenerative processes. Their
absence at any age tested suggests that mutant astrocytes (and their
neighbors) are not distressed by the lack of mitochondrial respira-
tion. BG cells play an important role in maintaining the physiology
and plasticity of synapses between PFs and PF dendrites (Saab et al.,
2012). The densities of cerebellar PF–PC synapses and the area oc-
cupied by astrocytic processes enwrapping these synapses was the
same in mutant and control mice.
Our data do not suggest that astrocytes do not require mito-
chondrial respiration. In postnatal development, during cellular
growth, and after CNS injury, it is even likely that normal astro-
cyte behavior requires mitochondrial ATP generation. However,
our work provides in vivo evidence that in the adult steady-state
respiration-deficient BG cells survive normally, which necessi-
tates that they generate ATP merely by aerobic glycolysis. The
data also imply that these astrocytes at least are a continuous
source (not a sink) of lactate; that is, not for short time, but rather
for 1 year or more. In the cerebellum, this applies to90% of all
BG cells in the absence of any sign of pathology or cerebellar
dysfunction. Although it remains a theoretical possibility that
lactate fluxes are very different in wild-type mice, we take our
Figure 7. BG cell processes covering PC synapses. A, Electron micrographs showing BG processes (false-colored in pink) at PF–PC synapses, marked with asterisks, in the upper third of the
molecular layer. Images frommutant and control mice are indistinguishable (age 9–10months). Scale bar, 1m. B, PF–PC synapse density in the upper part of themolecular layer was unaltered
inmutantmice at the indicated ages. C, PC synapses are normally covered by BG processes inmutantmice at both time points.D, Calculatedmitochondrial density of BG processes was unaltered in
mutant mice compared with controls. Data shown as mean SEM. n.s., Not significant.
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phenotypical data as strong supportive in vivo evidence for a
model of astrocytes as naturally glycolytic cells.
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